News

Goldman Sachs Keeps Their Sell Rating on Medtronic (MDT)
Goldman Sachs analyst David Roman reiterated a Sell rating on Medtronic today and set a price target of $78.00. The company’s shares closed today at $89.92. Take advantage of TipRanks Premium at 50% ...
CMS decision opens ‘massive’ patient pool for Medtronic, says BTIG
BTIG analyst Ryan Zimmerman keeps a Neutral rating on Medtronic (MDT) after Centers for Medicare and Medicaid Services ...